PECAM1 and neoplasm: The results demonstrated a significant overexpression of VEGFA, CD31 (a vascular marker), and CD133 (a marker for human hematopoietic precursor and EPC cells) in A549-PM xenograft tumor tissues compared to A549-Par tissues (Figure 4f–i).